|14.25||+0.04 / +0.28%|
Data as of 4:03pm ET
|14.43||+0.1774 / +1.24%|
The 4 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 20.50, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +43.86% increase from the last price of 14.25.
The current consensus among 5 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.